Creatinine =< 2.0 mg/dL [clinicaltrials_resource:0965933a5db9541ce31cbc81024fc069]
eligibility for clinicaltrials:NCT00466960 [clinicaltrials_resource:14f900538f728e0ebcd80809e4af0c55]eligibility for clinicaltrials:NCT00049127 [clinicaltrials_resource:22f90324d3f546160a14865aad267bc5]eligibility for clinicaltrials:NCT01706458 [clinicaltrials_resource:25432f00dd345a226242fcf0c161fa3d]eligibility for clinicaltrials:NCT01325311 [clinicaltrials_resource:30a0dd6046d116251601576d57cc8805]eligibility for clinicaltrials:NCT01580410 [clinicaltrials_resource:6459141cb9929d81c5945bf3f19b5ea2]eligibility for clinicaltrials:NCT02111941 [clinicaltrials_resource:6e4bd208fa1b15a0ab620a5eadfef438]eligibility for clinicaltrials:NCT02029950 [clinicaltrials_resource:93e61f48eae3366a78aebcccea201908]eligibility for clinicaltrials:NCT02504359 [clinicaltrials_resource:a7c128497c35f92bff5aebbf0cf942e0]eligibility for clinicaltrials:NCT01166126 [clinicaltrials_resource:aae50a00edfa5729915ee35b583e7a79]eligibility for clinicaltrials:NCT01334177 [clinicaltrials_resource:b817edcbc0ff1cfef5c415e3aa3b79dc]eligibility for clinicaltrials:NCT01527149 [clinicaltrials_resource:e63733d3cfa9663186ad84cb4ad475d0]eligibility for clinicaltrials:NCT02499835 [clinicaltrials_resource:fb92a274b2454fe10e1972ab8b67e904]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT01145508 [clinicaltrials_resource:05896916fb79370653c428a0d5fe0e4f]eligibility for clinicaltrials:NCT00337194 [clinicaltrials_resource:10ea5c228c130e9bc804de6aefe09754]eligibility for clinicaltrials:NCT00466960 [clinicaltrials_resource:14f900538f728e0ebcd80809e4af0c55]eligibility for clinicaltrials:NCT00049127 [clinicaltrials_resource:22f90324d3f546160a14865aad267bc5]eligibility for clinicaltrials:NCT01706458 [clinicaltrials_resource:25432f00dd345a226242fcf0c161fa3d]eligibility for clinicaltrials:NCT00462605 [clinicaltrials_resource:25be4fa5bad7974765ad9e6825c1bbc1]eligibility for clinicaltrials:NCT01325311 [clinicaltrials_resource:30a0dd6046d116251601576d57cc8805]eligibility for clinicaltrials:NCT00601900 [clinicaltrials_resource:36b461d136e65a338c35282e995f5614]eligibility for clinicaltrials:NCT02115282 [clinicaltrials_resource:3cca34437a0482793e25340b50079759]eligibility for clinicaltrials:NCT00470197 [clinicaltrials_resource:3ed3ca208233ac8cf36b24c16d12593b]eligibility for clinicaltrials:NCT00785291 [clinicaltrials_resource:56e8414e7aae4a3cb51827160e7f935f]eligibility for clinicaltrials:NCT00089154 [clinicaltrials_resource:5c48b112fec46672f8f07ebaa7d98610]eligibility for clinicaltrials:NCT01580410 [clinicaltrials_resource:6459141cb9929d81c5945bf3f19b5ea2]eligibility for clinicaltrials:NCT01286272 [clinicaltrials_resource:6d6e6eeb58eeaad063f6bc80559d910a]eligibility for clinicaltrials:NCT02111941 [clinicaltrials_resource:6e4bd208fa1b15a0ab620a5eadfef438]eligibility for clinicaltrials:NCT00060125 [clinicaltrials_resource:85a3d48d49808d081ae0ca30fa007e31]eligibility for clinicaltrials:NCT02029950 [clinicaltrials_resource:93e61f48eae3366a78aebcccea201908]eligibility for clinicaltrials:NCT02504359 [clinicaltrials_resource:a7c128497c35f92bff5aebbf0cf942e0]eligibility for clinicaltrials:NCT01166126 [clinicaltrials_resource:aae50a00edfa5729915ee35b583e7a79]eligibility for clinicaltrials:NCT01334177 [clinicaltrials_resource:b817edcbc0ff1cfef5c415e3aa3b79dc]eligibility for clinicaltrials:NCT00474812 [clinicaltrials_resource:e4c3b3caa0eba00f7dbde71c603db4b7]eligibility for clinicaltrials:NCT01527149 [clinicaltrials_resource:e63733d3cfa9663186ad84cb4ad475d0]eligibility for clinicaltrials:NCT00079378 [clinicaltrials_resource:e71bc5eeacdf2ab266d3f3c2f8ced3e0]eligibility for clinicaltrials:NCT02499835 [clinicaltrials_resource:fb92a274b2454fe10e1972ab8b67e904]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Creatinine =< 2.0 mg/dL [clinicaltrials_resource:0965933a5db9541ce31cbc81024fc069]
Bio2RDF identifier
0965933a5db9541ce31cbc81024fc069
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0965933a5db9541ce31cbc81024fc069
identifier
clinicaltrials_resource:0965933a5db9541ce31cbc81024fc069
title
Creatinine =< 2.0 mg/dL
@en
type
label
Creatinine =< 2.0 mg/dL [clinicaltrials_resource:0965933a5db9541ce31cbc81024fc069]
@en